Yaqi Zhou

Yaqi Zhou

Auto-generated profile, based on publicly available information

Yaqi Zhou

School of Basic Medical Sciences, Henan University, Kaifeng, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2024 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
YZYaqi Zhou
Yaqi Zhou
YXYaxuan Xiang
Yaxuan Xiang
SLSijie Liu
Sijie Liu
CLChenyao Li
Chenyao Li
JDJiaheng Dong
Jiaheng Dong
LZLei Zhang
Lei Zhang
Receptor-interacting protein kinase 3 (RIPK3), a member of the receptor-interacting protein kinase (RIPK) family with serine/threonine protein kinase activity, interacts with RIPK1 to generate necrosomes, which trigger caspase-independent programmed necrosis. As a vital component of necrosomes, RIPK3 plays an indispensable role in necroptosis, which is crucial for human life and health. In addition, RIPK3 participates in the pathological process of several infections, aseptic inflammatory diseases, and tumors (including tumor-promoting and -suppressive activities) by regulating autophagy, cell proliferation, and the metabolism and production of chemokines/cytokines. This review summarizes the recent research progress of the regulators of the RIPK3 signaling pathway and discusses the potential role of RIPK3/necroptosis in the aetiopathogenesis of various diseases. An in-depth understanding of the mechanisms and functions of RIPK3 may facilitate the development of novel therapeutic strategies.

29 April 2025 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
JDJiaheng Dong
Jiaheng Dong
JZJiale Zhang
Jiale Zhang
KYKunhou Yao
Kunhou Yao
XXXiao Xu
Xiao Xu
YZYaqi Zhou
Yaqi Zhou
CQchangjiang Qin
changjiang Qin
Necroptosis, a non-apoptotic mode of programmed cell death, is characterized by the disintegration of the plasma membrane, ultimately leading to cell perforation and rupture. Recent studies have disclosed the mechanism of necroptosis and its intimate link with nanomaterials. Nanomedicine represents a novel approach in the development of therapeutic agents utilizing nanomaterials to treat a range of cancers with high efficacy. This article provides an overview of the primary mechanism behind necroptosis, the current research progress in nanomaterials, their potential use in various diseases—notably cancer, safety precautions, and prospects. The goal is to aid in the development of nanomaterials for cancer treatment.